Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Lancet Neurology

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S1474-4422(10)70253-2PMID 21163445PMCID PMC3158385
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Brain immunohistopathological study in a patient with anti‐NMDAR encephalitis

  2011cited by this paper
• Afferent facilitation of corticomotor responses is increased by IgGs of patients with NMDA-receptor antibodies

  2011cited by this paper
• Isolated Hemidystonia Associated with NMDa Receptor Antibodies Introduction

  2011cited by this paper
• Anti-NMDA receptor encephalitis after TdaP–IPV booster vaccination: cause or coincidence?

  2011cited by this paper
• Anti-NMDA-receptor encephalitis in a 3 year old patient with chromosome 6p21.32 microdeletion including the HLA cluster.

  2011cited by this paper
• Anti-NMDA-Rezeptor-Enzephalitis

  2010cited by this paper
• Causes of encephalitis and differences in their clinical presentations in England: a multicentre, population-based prospective study.

  2010cited by this paper
• Antibodies to the GABA(B) receptor in limbic encephalitis with seizures: case series and characterisation of the antigen.

  2010cited by this paper
• Retrospective analysis of NMDA receptor antibodies in encephalitis of unknown origin

  2010cited by this paper
• Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan’s syndrome and acquired neuromyotonia

  2010cited by this paper
• Neurological sequelae of 2009 influenza A (H1N1) in children: A case series observed during a pandemic*

  2010cited by this paper
• Anti-N-methyl-D-aspartate receptor encephalitis during pregnancy.

  2010cited by this paper
• Anti-NMDA receptor encephalitis causing prolonged nonconvulsive status epilepticus

  2010cited by this paper
• Update on anti-N-methyl-D-aspartate receptor encephalitis in children and adolescents

  2010cited by this paper
• Postnatal NMDA receptor ablation in corticolimbic interneurons confers schizophrenia-like phenotypes

  2010cited by this paper
• Expanding Spectrum of Encephalitis With NMDA Receptor Antibodies in Young Children

  2010cited by this paper
• Reversible brain atrophy in anti-NMDA receptor encephalitis: a long-term observational study

  2010cited by this paper
• Acute Psychiatric Syndrome Leading Young Patients to ICU: Consider Anti-NMDA-Receptor Antibodies.

  2010cited by this paper
• Cortical hypometabolism demonstrated by PET in relapsing NMDA receptor encephalitis.

  2010cited by this paper
• FDG-PET hyperactivity in basal ganglia correlating with clinical course in anti–NDMA-R antibodies encephalitis

  2010cited by this paper
• Cellular and Synaptic Mechanisms of Anti-NMDA Receptor Encephalitis

  2010cited by this paper
• Anti-N-methyl-D-aspartate receptor antibodies: A potentially treatable cause of encephalitis in the intensive care unit

  2010cited by this paper
• Mechanisms underlying autoimmune synaptic encephalitis leading to disorders of memory, behavior and cognition: insights from molecular, cellular and synaptic studies

  2010cited by this paper
• Abnormal multifocal cerebral blood flow on Tc-99m HMPAO SPECT in a patient with anti-NMDA-receptor encephalitis

  2010cited by this paper
• Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels: a case series.

  2010cited by this paper
• In search of lost time from “Demonic Possession” to anti–N‐methyl‐D‐aspartate receptor encephalitis

  2010cited by this paper
• NMDA RECEPTOR ENCEPHALITIS MIMICKING SERONEGATIVE NEUROMYELITIS OPTICA

  2010cited by this paper
• N-methyl-d-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes

  2010cited by this paper
• RESPONSE TO IMMUNOTHERAPY IN A 20-MONTH-OLD BOY WITH ANTI-NMDA RECEPTOR ENCEPHALITIS

  2010cited by this paper
• Pearls & Oy-sters: Electroconvulsive therapy in anti-NMDA receptor encephalitis

  2010cited by this paper
• N‐methyl‐D‐aspartate receptor antibodies in pediatric dyskinetic encephalitis lethargica

  2009cited by this paper
• Reduced N‐acetylaspartate in the basal ganglia of a patient with anti‐NMDA receptor encephalitis

  2009cited by this paper
• AMPA receptor antibodies in limbic encephalitis alter synaptic receptor location

  2009cited by this paper
• Acute psychiatric illness in a young woman: an unusual form of encephalitis

  2009cited by this paper
• Evidence for antibody-mediated pathogenesis in anti-NMDAR encephalitis associated with ovarian teratoma

  2009cited by this paper
• Anti-NMDA receptor encephalitis: a video case report.

  2009cited by this paper
• Targeting the NMDA receptor subunit NR2B for the treatment of neuropathic pain

  2009cited by this paper
• Learning to breathe: control of the inspiratory–expiratory phase transition shifts from sensory‐ to central‐dominated during postnatal development in rats

  2009cited by this paper
• Diagnostic value of N-methyl-D-aspartate receptor antibodies in women with new-onset epilepsy.

  2009cited by this paper
• Anti‐NMDA receptor antibodies encephalitis

  2009cited by this paper
• Severe childhood encephalopathy with dyskinesia and prolonged cognitive disturbances: evidence for anti‐N‐methyl‐d‐aspartate receptor encephalitis

  2009cited by this paper
• Immune-Mediated Encephalitis and Virilization in Association with a Mature Cystic Ovarian Teratoma in an Adolescent Girl

  2009cited by this paper
• Anti-NMDA receptor encephalitis: report of ten cases and comparison with viral encephalitis

  2009cited by this paper
• Complex partial status epilepticus revealing anti-NMDA receptor encephalitis.

  2009cited by this paper
• Anti–N‐methyl‐D‐aspartate receptor (NMDAR) encephalitis in children and adolescents

  2009cited by this paper
• Propofol infusion syndrome in patients with refractory status epilepticus: An 11-year clinical experience*

  2009cited by this paper
• LIMBIC ENCEPHALITIS ASSOCIATED WITH ANTIBODIES TO THE NMDA RECEPTOR IN HODGKIN LYMPHOMA

  2009cited by this paper
• Inverse ocular bobbing in a patient with encephalitis associated with antibodies to the N-methyl-D-aspartate receptor.

  2008cited by this paper
• Case records of the Massachusetts General Hospital. Case 26-2008. A 26-year-old woman with headache and behavioral changes.

  2008cited by this paper
• RESPONSE OF ANTI-NMDA RECEPTOR ENCEPHALITIS WITHOUT TUMOR TO IMMUNOTHERAPY INCLUDING RITUXIMAB

  2008cited by this paper
• Paraneoplastic Anti–N-methyl-d-aspartate Receptor Encephalitis Associated with Ovarian Teratoma

  2008cited by this paper
• Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies.

  2008cited by this paper
• Anti-NMDA receptor encephalitis in Japan

  2008cited by this paper
• The distinctive movement disorder of ovarian teratoma‐associated encephalitis

  2008cited by this paper
• Pathogenic potential of IgG binding to water channel extracellular domain in neuromyelitis optica

  2007cited by this paper
• Neurological response to early removal of ovarian teratoma in anti-NMDAR encephalitis

  2007cited by this paper
• Paraneoplastic anti–N‐methyl‐D‐aspartate receptor encephalitis associated with ovarian teratoma

  2007cited by this paper
• A patient with encephalitis associated with NMDA receptor antibodies

  2007cited by this paper
• Involvement of a Dysfunctional Dopamine-D1/N-Methyl-d-aspartate-NR1 and Ca2+/Calmodulin-Dependent Protein Kinase II Pathway in the Impairment of Latent Learning in a Model of Schizophrenia Induced by Phencyclidine

  2007cited by this paper
• Accidental seizure with repetitive transcranial magnetic stimulation.

  2006cited by this paper
• Electroconvulsive therapy in a pediatric patient with malignant catatonia and paraneoplastic limbic encephalitis.

  2006cited by this paper
• Paraneoplastic encephalitis, psychiatric symptoms, and hypoventilation in ovarian teratoma

  2005cited by this paper
• Encephalitis.

  2005cited by this paper
• Dopamine is not Required for the Hyperlocomotor Response to NMDA Receptor Antagonists

  2005cited by this paper
• Associated autoimmune diseases in patients with the Lambert-Eaton myasthenic syndrome and their families

  2004cited by this paper
• Recommended diagnostic criteria for paraneoplastic neurological syndromes

  2004cited by this paper
• HLA‐B8 in Patients with the Lambert‐Eaton Myasthenic Syndrome Reduces Likelihood of Associated Small Cell Lung Carcinoma

  2003cited by this paper
• Differences in clinical features between the Lambert-Eaton myasthenic syndrome with and without cancer: an analysis of 227 published cases.

  2002cited by this paper
• Immune mediated chorea encephalopathy syndrome in childhood.

  2002cited by this paper
• Immunohistochemical analysis of anti-Hu-associated paraneoplastic encephalomyelitis

  2002cited by this paper
• Anti-Hu-associated paraneoplastic encephalomyelitis: analysis of 200 patients.

  2001cited by this paper
• The Universal Field Hypothesis of Catatonia and Neuroleptic Malignant Syndrome

  2000cited by this paper
• Ketamine abusers presenting to the emergency department: a case series.

  2000cited by this paper
• The Neuropsychopharmacology of Phencyclidine: From NMDA Receptor Hypofunction to the Dopamine Hypothesis of Schizophrenia

  1999cited by this paper
• Mice with reduced NMDA receptor expression display behaviors related to schizophrenia.

  1999cited by this paper
• Reversible limbic encephalitis caused by ovarian teratoma

  1997cited by this paper
• Coma with Abnormal Movements and Prolonged Cognitive Disturbances: A New Subset of Acute Encephalopathy

  1996cited by this paper
• Glutamate receptor dysfunction and schizophrenia.

  1995cited by this paper
• Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses.

  1994cited by this paper
• Coma associated with intense bursts of abnormal movements and long-lasting cognitive disturbances: an acute encephalopathy of obscure origin.

  1992cited by this paper
• Recent advances in the phencyclidine model of schizophrenia.

  1991cited by this paper
• The infant with anencephaly.

  1990cited by this paper
• Case records of the Massachusetts General Hospital.

  1990cited by this paper
• The infant with anencephaly.

  1990cited by this paper
• The effect of a single administration of phencyclidine on behavior in the rat over a 21-day period.

  1984cited by this paper
• Physostigmine and haloperidol treatment of acute phencyclidine intoxication.

  1982cited by this paper
• Acute phencyclidine intoxication: incidence of clinical findings in 1,000 cases.

  1981cited by this paper
• Acquired reversible autistic syndrome in acute encephalopathic illness in children.

  1981cited by this paper
• Identification of a street drug as N-ethyl-1-phenylcyclohexylamine, a phencyclidine analog.

  1978cited by this paper
• Myasthenic antibodies cross-link acetylcholine receptors to accelerate degradation.

  1978cited by this paper
• Study of a new schizophrenomimetic drug; sernyl.

  1959cited by this paper

• Immunotherapies on autoimmune encephalitis.

  2026cites this paper
• Anti-NMDA receptor encephalitis unmasking Sjögren’s disease: a case report and literature review

  2026cites this paper
• Autoimmune Encephalitis with Neuropsychiatric Manifestations Secondary to Anti-N Methyl-D-Aspartate Receptor Antibodies: A Comprehensive Case Analysis and Literature Review

  2026cites this paper
• Safety and efficacy of intrathecal rituximab in refractory neuroimmune disorders- a case series.

  2026cites this paper
• Lentiform fork sign mimicking uremic encephalopathy in an atypical case of autoimmune limbic encephalitis

  2026cites this paper
• N‑methyl‑D‑aspartate receptor dysregulation as a neuromarker of schizophrenia: A narrative review

  2026cites this paper
• Neuropsychiatric Systemic Lupus Erythematosus Diagnosed Following Treatment Initiated for Acute Encephalitis.

  2026cites this paper
• Autonomic nervous system autoimmunity and proposed immunotherapies.

  2026cites this paper
• Racial and Ethnic Disparities in Clinical Characteristics and Outcomes in Adults With Encephalitis: A Retrospective Study

  2026cites this paper
• Neutrophil-to-apolipoprotein A1 ratio as a novel biomarker for prognosis in anti-NMDAR encephalitis: a retrospective cohort analysis

  2026cites this paper
• Abnormal Magnetic Resonance Imaging Patterns in Patients with Neuropsychiatric Disorders Due to Anti-NMDA Receptor Encephalitis: A Comparative Study

  2026cites this paper
• Impact of sex differences on clinical characteristics of anti-N-methyl-D-aspartate receptor encephalitis during the acute phase: a single-center retrospective study

  2026cites this paper
• Early Ovarian Teratoma Resection Improves Outcomes in Anti–N-Methyl-D-Aspartate Receptor Encephalitis: A Dual-Case Series

  2026cites this paper
• CAR T-Cell Immunotherapy in Neuroautoimmune Diseases: Focus on the Central Nervous System.

  2026cites this paper
• Role of serum complement C3 in blood-brain barrier injury and prognosis of anti-NMDAR encephalitis.

  2026cites this paper
• Clinical characteristics of MOG antibody-positive anti-NMDAR encephalitis: a single-center retrospective study

  2026cites this paper
• Paraneoplastic neurologic disorders and neurologic complications of immune checkpoint inhibitors.

  2026cites this paper
• Seizure characteristics and neurological outcomes in pediatric anti-NMDAR encephalitis: a cohort study from Southern China

  2026cites this paper
• Decoding Neurotransmitter and Genetic Contributions to Abnormal Neuronal Signal Variability in Anti‑N‑Methyl‑D‑Aspartate Receptor Encephalitis: Implications for Targeted Therapies.

  2026cites this paper
• Immunoregulatory programs in anti‐N‐methyl‐D‐aspartate receptor encephalitis identified by single‐cell multi‐omics analysis

  2025cites this paper
• Cognitive Outcome in a Case of Herpes Simplex Virus Encephalitis-induced Anti-N-methyl-D-aspartate Receptor Encephalitis

  2025cites this paper
• Clinical Analysis of MOG Antibody‐Associated Disease Overlapped With Anti‐NMDA Receptor Encephalitis: A Long‐Term Retrospective Study

  2025cites this paper
• Paraneoplastic syndromes in ovarian cancer: Clinical manifestations, mechanisms and management challenges.

  2025cites this paper
• Autoimmune Psychosis Exists: Early Diagnosis of an Anti‐NMDA Receptor Autoimmune Encephalitis Presenting as First‐Episode Psychosis in a 25‐Year‐Old Male—A Case Report

  2025cites this paper
• The Spectrum of Abnormal Tongue Movements: Review of Phenomenology, Etiology, and Differential Diagnosis.

  2025cites this paper
• Efgartigimod-rituximab sequential therapy in Anti-NMDAR encephalitis: real-world evidence for a novel salvage-maintenance strategy

  2025cites this paper
• Altered brain activity during working memory in adult patients with anti-NMDAR encephalitis.

  2025cites this paper
• Trapped in Silence: Severe Catatonia From Anti-N-Methyl-D-Aspartate (NMDA) Receptor Encephalitis in a Neurofibromatosis Type 1 Patient With Craniopharyngioma

  2025cites this paper
• Functional Connectivity Changes of Anti‐N‐Methyl‐D‐Aspartate Receptor Encephalitis: A Graph‐Theoretic and Topology‐Based Study

  2025cites this paper
• Autoimmune Encephalitis.

  2025cites this paper
• HBEGF/EGFR pathway activation by hUC-MSCs improves cognitive outcomes in anti-NMDAR encephalitis.

  2025cites this paper
• Brain Atrophy Can Predict the Severity and Prognosis of Anti-N-Methyl-D-Aspartate Receptor Encephalitis

  2025cites this paper
• Analysis of Prognostic Influencing Factors in Children with Autoimmune Encephalitis

  2025cites this paper
• Safety and Efficacy of a Neonatal Fc Receptor Antagonist in Patients With Anti‐NMDAR Encephalitis

  2025cites this paper
• Anti-alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor encephalitis presenting as catatonia

  2025cites this paper
• Diffuse neuropsychiatric lupus: Clinical evidence, immune-mediated mechanisms, and therapeutic insights.

  2025cites this paper
• Functional connectivity is linked to symbolic BOLD patterns: replication, extension, and clinical application of the human ‘complexome’

  2025cites this paper
• Exosomal miR-432-5p, miR-4433b-5p, and miR-599: Biomarkers for Monitoring the Severity of Anti-N-methyl-D-aspartate Receptor Encephalitis.

  2025cites this paper
• Intraperitoneal administration of NMDA-Subunit NR1-receptor antibodies does not improve long-term outcome in a murine MCAo-stroke model

  2025cites this paper
• Clinical and Brain MRI Characteristics of Patients with Anti-N-Methyl-d-Aspartate Receptor Encephalitis: A 10-Year Retrospective Study

  2025cites this paper
• Case Report on Autoimmune Encephalitis Manifesting as Psychosis

  2025cites this paper
• Harnessing Patient-Derived Antibodies-Induced Microglial Complement 1q Expression: A Novel Therapeutic Approach for Anti-NMDAR Encephalitis.

  2025cites this paper
• Successful Early Treatment of Anti‐N‐Methyl‐d‐Aspartate Receptor Encephalitis Associated With Small Cell Lung Cancer in an Elderly Male Patient: A Case Report

  2025cites this paper
• The relationship between patient-reported quality of life and clinician-rated outcome scores in patients with autoimmune encephalitis: a study of the Australian Autoimmune Encephalitis Consortium

  2025cites this paper
• Subgroup analysis of tumefactive demyelinating lesions: clinical, imaging features and outcomes

  2025cites this paper
• Clinical features and prognosis of the adult patients positive for both N-methyl-d-aspartate receptor and myelin oligodendrocyte glycoprotein antibodies

  2025cites this paper
• Paraneoplastic Anti-NMDA Receptor Encephalitis in a Nigerian Female Teenager: A Case Report.

  2025cites this paper
• The gut-brain axis: potential reshaping the future of anti-NMDAR encephalitis treatment

  2025cites this paper
• Personalized Ofatumumab therapy for autoimmune encephalitis: A case series of four patients.

  2025cites this paper
• Risk factors for central hypoventilation in anti-N-methyl-D-aspartate receptor encephalitis

  2025cites this paper
• Biomarkers on anti-N-methyl-D-aspartate receptor encephalitis

  2025cites this paper
• Anti-NMDA receptor encephalitis in a child with H3K27M mutant pontine diffuse midline glioma

  2025cites this paper
• A Phase-2B Double-Blind Randomized International Prospective Trial of Inebilizumab in NMDAR Encephalitis: The ExTINGUISH Trial.

  2025cites this paper
• Neuroimmunology and Sleep

  2025cites this paper
• Three Cases of Relapses of Anti-N-methyl-D-aspartate Receptor Encephalitis: Tertiary Center Experience

  2025cites this paper
• Recurrent Epilepsy 14 Days After Surgery in Teratoma-Associated Anti-NMDAR Encephalitis: A Case Report

  2025cites this paper
• Cognitive outcomes and performance of patients diagnosed and treated for N-Methyl-D-Aspartate receptor antibody-mediated (NMDAR) encephalitis compared with patients with schizophrenia and healthy controls.

  2025cites this paper
• A Case of Anti-N-Methyl-D-Aspartate Receptor (NMDAR) Encephalitis With Video-Documented Psychogenic Nonepileptic Seizures (PNES)-Mimicking Episodes Initially Considered as Somatic Symptom Disorder

  2025cites this paper
• Intrathecal treatment of Anti-N-Methyl-D-Aspartate receptor encephalitis: a promising approach for refractory cases

  2025cites this paper
• PSYCHIATRIC SYMPTOM IN ANTI N-METHYL D-ASPARTATE RECEPTOR (NMDAR) ENCEPHALITIS, HOW TO ASSES?

  2025cites this paper
• Autoimmune dementia

  2025cites this paper
• Successful treatment with efgartigimod as an add-on therapy for acute attack of anti-NMDA receptor encephalitis: a case report

  2025cites this paper
• Pediatric Unilateral Optic Neuritis Associated with Double-Positive Anti-Myelin Oligodendrocyte Glycoprotein and Anti-N-Methyl-D-Aspartate Receptor Antibodies: A Case Report and Literature Review

  2025cites this paper
• Anti-NMDA receptor encephalitis following Murray Valley encephalitis: a case report

  2025cites this paper
• Successful sequential therapy with rituximab and telitacicept in refractory Anti-NMDA receptor encephalitis and MOG-associated demyelination: a case report and literature review

  2025cites this paper
• Machine learning for the early prediction of long-term cognitive outcome in autoimmune encephalitis.

  2025cites this paper
• Anti-metabotropic glutamate receptor 5 coexistent anti-N-methyl-D-aspartate receptor encephalitis: a case report and literature review

  2025cites this paper
• Clinical and imaging features and treatment response of anti-NMDAR encephalitis combined with MOGAD.

  2025cites this paper
• Abnormal Brain MRI in Anti-NMDA Receptor Encephalitis

  2025cites this paper
• Long-term maintenance of mycophenolate mofetil in anti-NMDA receptor encephalitis (LEARN): a multicentre, open-label, blinded-endpoint, randomised controlled trial

  2025cites this paper
• Anti-NMDA Receptor Encephalitis Secondary to a Mature Cystic Teratoma in a Female Teenager: A Case Report

  2025cites this paper
• MOG-Encephalitis is the Most Prevalent Autoimmune Encephalitis in Children: MERIN Study Data on Encephalitis

  2025cites this paper
• A case report of NMDAR encephalopathy - A neurologic condition that a gynecologist can cure

  2025cites this paper
• GTE score on evaluating the degree of neurological impairment in anti-NMDA receptor encephalitis

  2025cites this paper
• Development of anti-NMDA receptor encephalitis in a patient with multiple sclerosis

  2025cites this paper
• Autoimmune-related movement disorders.

  2025cites this paper
• Anti-NMDA Receptor Encephalitis: A Narrative Review

  2025influential citation
• Cryptogenic Encephalitis: The New Abnormal

  2025cites this paper
• Characteristics and Changes of Cingulate Gyrus Function and Perfusion in Patients With Anti‐N‐Methyl‐D‐Aspartate Receptor Encephalitis

  2025cites this paper
• The spectrum of overlapping anti-NMDAR encephalitis and demyelinating syndromes: a systematic review of presentation, diagnosis, management, and outcomes

  2025cites this paper
• A case report of anti-N-methyl-ᴅ-aspartate receptor encephalitis: prioritizing clinical symptoms over diagnostic test results

  2025cites this paper
• Behandlung neuroimmunologischer Erkrankungen mit CAR-T-Zellen

  2025cites this paper
• Anti-NMDAR encephalitis triggered by EBV and HSV-1: A case report and literature review

  2025cites this paper
• Consenso Argentino de Diagnóstico y Tratamiento de Encefalitis Autoinmune en Adultos (CARENAI)

  2025cites this paper
• Outcomes of Therapeutic Plasma Exchange Among Children With Autoimmune Encephalitis in Vietnam

  2025cites this paper
• Autoantibodies against myelin oligodendrocyte glycoprotein in a subgroup of patients with psychotic symptoms

  2025cites this paper
• Oligoclonal Bands as Predictors of Disease Severity and Prognosis in Anti-NMDAR Encephalitis

  2025cites this paper
• Comparative efficacy of intravenous immunoglobulin and protein A immunoadsorption in severe anti-NMDAR encephalitis

  2025cites this paper
• Next-generation approaches in autoimmune encephalitis diagnosis: A multi-omics perspective.

  2025cites this paper
• Aberrant lncRNA and mRNA expression in patients with anti-N-methyl-d-aspartate receptor encephalitis

  2025cites this paper
• Cell-free DNA integrity and complement C4d as novel liquid biopsy biomarkers for paraneoplastic and non-paraneoplastic autoimmune encephalitis

  2025cites this paper
• Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with small cell lung cancer: A dramatic recovery after chemotherapy.

  2025cites this paper
• N-Methyl-D-Aspartate (NMDA) Receptor Encephalitis Without Electroencephalogram Abnormalities or Cerebrospinal Fluid Pleocytosis Associated With a Tiny Ovarian Teratoma: A Case Report

  2025cites this paper
• Anti–N-methyl-ᴅ-aspartate receptor encephalitis in India: a case series and review of the literature

  2025cites this paper
• Interference between immune cells and insomnia: a bibliometric analysis from 2000 to 2023

  2025cites this paper
• Paraneoplastic syndromes in ovarian carcinoma: A study on clinical spectrum, treatment and survival perspectives.

  2025cites this paper
• Mechanisms of Autoimmune Encephalitis-Related Cognitive Impairment and Advances in Traditional Chinese and Western Medicine Treatments

  2025cites this paper
• Phenobarbital for Refractory Behavioral Disturbances in Anti-NMDAR and HSV Encephalitis: A Case Report.

  2025cites this paper
• Rapidly progressive dementia in a middle-aged woman: A case of probable sporadic Creutzfeldt-Jakob disease

  2025cites this paper
• Spectrum of movement disorders in Japanese encephalitis: a systematic review of case reports, case series, and cohort studies.

  2025cites this paper